Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05799014
Other study ID # 2022-NHLHCRF-LX-01-0201-01
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 30, 2023
Est. completion date December 31, 2024

Study information

Verified date March 2023
Source China-Japan Friendship Hospital
Contact Mingming Deng, MD
Phone 86 18801336854
Email isdeng1017@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to evaluate the diagnostic efficacy and safety of percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology in peripheral lung lesions. The main question it aims to answer are: the effectiveness and safety of percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology. Participants will undergo CT-guided percutaneous lung biopsy or percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology.


Read more »

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
CT-guided percutaneous lung biopsy
The participants would undergo CT-guided percutaneous lung biopsy.
Percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology
The participants would undergo percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
China-Japan Friendship Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic accuracy of percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology for diagnosis of pleural effusion. The diagnosis would be confirmed according to the pathological results or multidisciplinary discussion results (if interstitial lung disease is suspected, the multidisciplinary discussion results shall be recorded).
The diagnostic efficacy of percutaneous lung biopsy guided by electromagnetic navigation real-time positioning technology will be compared with that of CT-guided percutaneous lung biopsy for diagnosis of pleural effusion.
7 days after the lung biopsy
Secondary Operation time Timer during the operation of lung biopsy
See also
  Status Clinical Trial Phase
Completed NCT04066699 - Percutaneous Localization: Open-label Registry of Thoracic Surgery
Recruiting NCT06412289 - Comparison of the Diagnostic Accuracy Between US-guided Percutaneous Lung Biopsies vs CT-guided in Peripheral Lung Lesions N/A
Completed NCT02582944 - Electromagnetic Navigation for Peripheral Pulmonary Lesions Phase 1
Recruiting NCT05752227 - Difference Strain Ratio Ultrasound Elastography Between Benign and Malignant Peripheral Lung Lesions
Withdrawn NCT03536026 - Localization of Peripheral Pulmonary Lesions: A Pilot Study Phase 1